Cargando…
MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib
BACKGROUND: Triple-negative breast cancers (TNBC) are heterogeneous cancers with poor prognosis. We aimed to determine the clinical relevance of membrane type-4 matrix metalloproteinase (MT4-MMP), a membrane type matrix metalloproteinase that interacts with epidermal growth factor receptor (EGFR) ov...
Autores principales: | Yip, Cassandre, Foidart, Pierre, Somja, Joan, Truong, Alice, Lienard, Mehdi, Feyereisen, Emilie, Schroeder, Hélène, Gofflot, Stéphanie, Donneau, Anne-Françoise, Collignon, Joëlle, Delvenne, Philippe, Sounni, Nor Eddine, Jerusalem, Guy, Noël, Agnès |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355928/ https://www.ncbi.nlm.nih.gov/pubmed/28196064 http://dx.doi.org/10.1038/bjc.2017.23 |
Ejemplares similares
-
MT4-MMP: The GPI-Anchored Membrane-Type Matrix Metalloprotease with Multiple Functions in Diseases
por: Yip, Cassandre, et al.
Publicado: (2019) -
Molecular Mechanisms Driven by MT4-MMP in Cancer Progression
por: Muñoz-Sáez, Emma, et al.
Publicado: (2023) -
MT-MMPS as Regulators of Vessel Stability Associated with Angiogenesis
por: Sounni, Nor Eddine, et al.
Publicado: (2011) -
MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells
por: Sodek, K L, et al.
Publicado: (2007) -
Radiation-induced lung metastasis development is MT1-MMP-dependent in a triple-negative breast cancer mouse model
por: Bouchard, Gina, et al.
Publicado: (2017)